Publication Cover
Accountability in Research
Ethics, Integrity and Policy
Volume 25, 2018 - Issue 4
370
Views
18
CrossRef citations to date
0
Altmetric
Articles

Scientific authorship, pluralism, and practice

, Ph.D.

References

  • Flanigan, A., L. A. Carey, P. B. Fontanarosa, S. G. Phillips, B. P. Pace, G. D. Lundberg, and D. Rennie. 1998. Prevalence of articles with honorary authors and ghost authors in peer reviewed medical journals. JAMA 280:222–24. doi:10.1001/jama.280.3.222.
  • Fugh-Berman, A. 2005. The corporate coauthor. Journal of General Internal Medicine 20:546–48. doi:10.1111/j.1525-1497.2005.05857.x.
  • Fugh-Berman, A. 2010. The haunting of medical journals: How ghostwriting sold “HRT”. PLoS Medicine 7 (9):e1000335. doi:10.1371/journal.pmed.1000335.
  • Gøtzsche, P. C., A. Hróbjartsson, H. K. Johansen, M. T. Haahr, D. G. Altman, and A. Chan. 2007. Ghost authorship in industry-initiated randomized trials. PLoS Medicine 4:e19. doi:10.1371/journal.pmed.0040019.
  • International Committee of Medical Journal Editors. 2013. Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publications. Accessed March 30, 2013. http://www.icmje.org/.
  • International Committee of Medical Journal Editors. 2017. Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publications. Accessed December 26, 2017. http://www.icmje.org/.
  • Kellert, S., H. Longino, and C. K. Waters, eds. 2006. Scientific pluralism (Minnesota studies in the philosophy of science, Vol. XIX). Minneapolis: University of Minnesota Press.
  • Le Noury, J., J. M. Nardo, D. Healy, J. Jureidini, M. Raven, C. Tufanaru, et al. 2015. Restoring study 329: Efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence. BMJ 351:h4320. doi:10.1136/bmj.h4320.
  • McHenry, L. B., and J. Jureidini. 2008. Industry-sponsored ghostwriting in clinical trial reporting: A case study. Accountability in Research 15 (3):152–67. doi:10.1080/08989620802194384.
  • Moffatt, B. 2007. Ghostwriting study needs clearer justification of criterion for authorship. online response to Gøtzsche P.C, Hróbjartsson A., Johansen H.K., Haahr, M.T., Altman, D.G., et al. 2007. “Ghost authorship in industry-initiated randomised trials.”. PLoS Medicine 4 (1):e19.
  • Moffatt, B. 2011. Responsible authorship: Why researchers must forgo honorary authorship. Accountability in Research 18 (2):76-90.
  • Moffatt, B. 2013. Orphan articles and ghostwriting: The case against the ICMJE criterion of authorship. Accountability in Research 20 (2):59–71. doi:10.1080/08989621.2013.767115.
  • Moffatt, B., and C. Elliott. 2007. Ghost marketing: Pharmaceutical companies and ghostwritten journal articles. Perspectives in Biology and Philosophy 50:18–31. doi:10.1353/pbm.2007.0009.
  • Mowatt, G., L. Shirran, J. M. Grimshaw, D. Rennie, A. Flanagin, V. Yank, G. MacLennan, P. C. Gøtzsche, and L. A. Bero. 2002. Prevalence of articles with honorary authors and ghost authors in Cochrane reviews. Jama 287:2769–71. doi:10.1001/jama.287.21.2769.
  • Neurology. 2013. Authorship definition. Accessed March 30, 2013. http://www.neurology.org/site/misc/auth2.html#AUTHORSHIPDEFINTION.
  • Resnik, D. B. 1996. Social epistemology and the ethics of research. Studies in History and Philosophy of Science Part A 27 (4):565–86. doi:10.1016/0039-3681(96)00043-X.
  • Ross, J. S., K. P. Hill, D. S. Egilman, and H. M. Krumholz. 2008. Guest authorship and ghostwriting in publications related to rofecoxib: A case study of industry documents from rofecoxib litigation. JAMA 299:1800–12. doi:10.1001/jama.299.15.1800.
  • Seeman, J. I., and M. C. House. 2015. Authorship issues and conflict in the U.S. academic chemical community. Accountability in Research 22 (6):346–83. doi:10.1080/08989621.2015.1047707.
  • Shamoo, A., and D. Resnik. 2015. Responsible conduct of research. 3rd ed. New York: Oxford University Press.
  • Sismondo, S. 2007. Ghost management: How much of the medical literature is shaped behind the scenes by the pharmaceutical industry? PLoS Medicine 4 (9):e286. doi:10.1371/journal.pmed.0040286.
  • Sismondo, S. 2009. Ghosts in the machine publication planning in the medical sciences. Social Studies of Science 39:171–98. doi:10.1177/0306312708101047.
  • Smith, E. 2017. A theoretical foundation for the ethical distribution of authorship in multidisciplinary publications. Kennedy Institute Ethics Journal 27 (3):371–411. doi:10.1353/ken.2017.0032.
  • Trinkle, B., T. Phillips, A. Hall, and B. Moffatt. 2017. Neutralising fair credit: Factors that influence unethical authorship practices. Journal of Medical Ethics 43 (6):368–73. doi:10.1136/medethics-2015-103365.
  • University of Pittsburgh. 2006. Summary investigative report on allegations of possible scientific misconduct on the part of Gerald P. Schatten, Ph.D.. Accessed December 26, 2017. https://ecommons.cornell.edu/bitstream/handle/1813/11589/Gerald_Schatten_Final_Report_2.08.pdf?sequence=1&isAllowed=y.
  • Walsh, J. 2012. Medtronic’s pull influenced Infuse articles, report finds. Star Tribune. Accessed September 15, 2013. http://www.startribune.com/lifestyle/health/175804281.html.
  • Wislar, J., A. Flanagin, P. B. Fontanarosa, and C. D. DeAngelis. 2011. Honorary and ghost authorship in high impact biomedical journals: Across sectional survey. BMJ 343:d6128. doi:10.1136/bmj.d6128.
  • World Association of Medical Editors. 2013. Criteria for authorship. Accessed March 30, 2013. http://www.wame.org/resources/policies#authorship.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.